Latest updates, from us and our ventures
Q1 2019
Congratulations to our own VP, Head of #Legal @RobinWalker for being honored as one of Mass. Lawyers Weekly’s (… https://t.co/KFQZUQrlQ0
— Casebia Therapeutics (@casebiatx) January 23, 2019
As the longest US government #shutdown in federal history continues, more and more industries are feeling the pinch… https://t.co/aBsqxLWZCm
— Leaps by Bayer (@LeapsByBayer) January 23, 2019
.@Phacilitate and the @WSCSummit are coming together to host the entire advanced therapies ecosystem! We are excite… https://t.co/Qk20P7iugR
— BlueRock (@BlueRockTx) January 22, 2019
Making the city a cleaner place! Watch to learn about this concrete tested in Poland that filters pollution into sa… https://t.co/O0nBg93LfZ
— Leaps by Bayer (@LeapsByBayer) January 21, 2019
Emile Nuwaysir is leading the BlueRock team to develop our novel #CellplusGene platform. Learn more about our techn… https://t.co/GC62FmIwko
— BlueRock (@BlueRockTx) January 18, 2019
Emil Nuwaysir is leading the BlueRock team to develop our novel #CellplusGene platform. Learn more about our techno… https://t.co/wIIJMEMqHQ
— BlueRock (@BlueRockTx) January 18, 2019
Join the BlueRock team! We are looking for an #IP and #contracts #attorney, #IT associate, head of #IR and an… https://t.co/AnVRgnKbwN
— BlueRock (@BlueRockTx) January 16, 2019
Today our team grows even stronger as we announce partnerships with two leading experts in autoimmune diseases. Wel… https://t.co/enQxJAUqYe
— BlueRock (@BlueRockTx) January 16, 2019
Ever wondered what a wind turbine made out of 146,000 LEGO bricks would look like? @LEGO_Group has built one in ord… https://t.co/Mp0BSIRBwt
— Leaps by Bayer (@LeapsByBayer) January 16, 2019
RT @MichaelJFoxOrg: If you're feeling at a loss for ways to help a friend diagnosed with #Parkinsons disease, start with these suggestions…
— BlueRock (@BlueRockTx) January 14, 2019
What if open brain surgery wasn't necessary anymore? Parkinson's disease faces a potential new and minimal invasive… https://t.co/RWV5fjjVZH
— Leaps by Bayer (@LeapsByBayer) January 14, 2019
What a week! Thank you #SanFrancisco for welcoming us to your city. Yet another productive year at #JPM19! See ever… https://t.co/9j2uTOYomj
— BlueRock (@BlueRockTx) January 10, 2019
A completely cancer-free patient after being diagnosed with and treated for metastatic breast cancer: This is a maj… https://t.co/vLo3sJcXtz
— Leaps by Bayer (@LeapsByBayer) January 10, 2019
Thanks to the @STATNews #Biotech team for hosting The Readout Live at #JPM19. Here's our CEO Jim Burns catching up… https://t.co/cuxJvHE78e
— Casebia Therapeutics (@casebiatx) January 10, 2019
BlueRock's Eric Soller had a great time discussing innovation in CNS drug development and the use of novel… https://t.co/ypDQL4dGmA
— BlueRock (@BlueRockTx) January 09, 2019
A new institute seeded by Paul Allen with $125 million has started studying the immune system in three unprecedente… https://t.co/5H6Eoadksa
— Leaps by Bayer (@LeapsByBayer) January 08, 2019
Earlier today, our CEO Jim Burns joined discussions with @alliancerm CEO Janet Lynch Lambert and other members as p… https://t.co/b3ap3ISvqF
— Casebia Therapeutics (@casebiatx) January 07, 2019
The Casebia team has arrived – we are excited to participate in #JPM19! From today’s ARM (@alliancerm) Cell & Gene… https://t.co/jKcZTlHxph
— Casebia Therapeutics (@casebiatx) January 07, 2019
Thought For Food™ focus on addressing the unique needs and challenges facing the food and agriculture sector, which… https://t.co/x1SRQVxR0t
— Leaps by Bayer (@LeapsByBayer) January 04, 2019
We will be joined by the greatest industry leaders from across the country at the 37th Annual @jpmorgan #Healthcare… https://t.co/OcPQAruxju
— BlueRock (@BlueRockTx) January 02, 2019
Operating the world's first medical drone delivery system, Zipline improves access to scarce supplies like blood an… https://t.co/3WZdz4Au2k
— Leaps by Bayer (@LeapsByBayer) January 02, 2019